Cargando…
Ulipristal acetate as a treatment option for uterine fibroids
Uterine fibroids are the most common benign uterine tumours. Clinical symptoms include abnormal bleeding, pelvic pressure, pelvic pain, infertility and obstetric complications. Approximately one third of women with fibroids will require treatment. The management also depends on the number, size, and...
Autores principales: | Piecak, Karolina, Milart, Paweł, Woźniakowska, Ewa, Paszkowski, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824685/ https://www.ncbi.nlm.nih.gov/pubmed/29483856 http://dx.doi.org/10.5114/pm.2017.72792 |
Ejemplares similares
-
The effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up
por: Woźniak, Sławomir, et al.
Publicado: (2014) -
Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve – an observational study
por: Czuczwar, Piotr, et al.
Publicado: (2018) -
Predicting the results of uterine artery embolization: correlation between initial intramural fibroid volume and percentage volume decrease
por: Czuczwar, Piotr, et al.
Publicado: (2014) -
Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids
por: Biglia, Nicoletta, et al.
Publicado: (2014) -
Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
por: Trefoux Bourdet, Alice, et al.
Publicado: (2015)